Eli Lilly Obesity Drug Poised To Blow Up Weight Loss Industry
Tirzepatide, an Eli Lilly and Co. obesity drug approved to treat type 2 diabetes, is poised to blow up the weight loss industry.
Tirzepatide, an Eli Lilly and Co. obesity drug approved to treat type 2 diabetes, is poised to blow up the weight loss industry.
To make this site work properly, we sometimes place small data files called cookies on your device. Most big websites do this too.